Teva Receives FDA Approval Of Trazodone 150mg Tablets.JERUSALEM, Israel--(BUSINESS WIRE)--May 1, 1997--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVIY) today announced that it has received approval from the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) to manufacture and market Trazodone trazodone /tra·zo·done/ (tra´zo-don) an antidepressant, used as the hydrochloride salt to treat major depressive episodes with or without prominent anxiety. 150mg tablets. Teva previously received FDA approval for 50mg and 100mg dosage strengths. Trazodone is the generic equivalent of Bristol Meyers Squibb's Desyrel7, an antidepresent, with U.S. sales of approximately $33 million. Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Ltd., is Israel's largest pharmaceutical company, with three quarters of its sales outside Israel, mainly in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The Company develops, manufactures and markets branded and generic human pharmaceuticals, bulk pharmaceutical chemicals, medical disposable and veterinary products. CONTACT: Teva Pharmaceutical Industries Ltd. Dan Suesskind, (011) 9722-5-892-840 or Morgen-Walke Associates, Inc. Investor Relations Investor relations The process by which the corporation communicates with its investors. : Donna N. Stein Press: Richard Dukas, 212/850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion